Successful treatment of mogamulizumab‐resistant mycosis fungoides with mogamulizumab plus etoposide combined therapy: Investigation of the immunomodulatory effects of etoposide on the tumor microenvironment-Reference-Cited by-同舟云学术

Successful treatment of mogamulizumab‐resistant mycosis fungoides with mogamulizumab plus etoposide combined therapy: Investigation of the immunomodulatory effects of etoposide on the tumor microenvironment

Published:2020-05-22 Issue:4 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Ohuchi Kentaro¹,Fujimura Taku¹^ORCID,Kambayashi Yumi¹,Amagai Ryo¹,Lyu Chunbing¹,Tanita Kayo¹,Sato Yota¹,Aiba Setsuya¹

Affiliation:

1. Department of Dermatology Tohoku University Graduate School of Medicine Sendai Japan

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.13487

Reference12 articles.

Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma

2. Mogamulizumab for the treatment of cutaneous T-cell lymphoma: recent advances and clinical potential

3. Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma

4. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

5. The possible interaction between periostin expressed by cancer stroma and tumor-associated macrophages in developing mycosis fungoides

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Next top” mouse models advancing CTCL research;Frontiers in Cell and Developmental Biology;2024-04-10

2. Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review;International Journal of Molecular Sciences;2024-02-12

3. Etoposide: A rider on the cytokine storm;Cytokine;2023-08

4. Cutaneous T cell lymphoma treated with mogamulizumab monotherapy and mogamulizumab plus etoposide combined therapy: A real‐world case series;Dermatologic Therapy;2022-10

5. CCR4 in cutaneous T‐cell lymphoma: Therapeutic targeting of a pathogenic driver;European Journal of Immunology;2021-05-07